A$301.84
How to buy shares in CSL
To buy shares listed in Australia such as CSL, you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose or you can see our list of the best share trading platforms in Australia. Then follow these steps.
-
Open and fund your brokerage account. Complete an application with your personal and financial details, including your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
-
Search for CSL. Find the share by name or ticker symbol: CSL. Research its history to confirm it's a solid investment against your financial goals.
-
Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until CSL reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
-
Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
-
Check on your investment. Congratulations, you own a part of CSL. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
CSL stock price (ASX:CSL)
Use our graph to track the performance of CSL stocks over time.CSL shares at a glance
52-week range | $225.5626 - $311.2777 |
---|---|
50-day moving average | $305.6148 |
200-day moving average | $289.7615 |
Target price | $327.3 |
PE ratio | 36.5335 |
Dividend yield | $2.64 (1.33%) |
Earnings per share (TTM) | $8.21 |
Is it a good time to buy CSL stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
CSL price performance over time
Historical closes compared with the last close of A$300.26
1 week (2024-09-05) | -0.94% |
---|---|
1 month (2024-08-15) | -0.29% |
3 months (2024-06-14) | 3.86% |
6 months (2024-03-15) | 7.16% |
1 year (2023-09-15) | 12.18% |
---|---|
2 years (2022-09-15) | 4.40% |
3 years (2021-09-15) | -1.52% |
5 years (2019-09-13) | 30.16% |
Is CSL under- or over-valued?
Valuing CSL stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CSL's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CSL's P/E ratio
CSL's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 37x. In other words, CSL shares trade at around 37x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
CSL's EBITDA
CSL's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.6 billion (£2.4 billion).
The EBITDA is a measure of a CSL's overall financial performance and is widely used to measure stock profitability.
CSL financials
Revenue TTM | $14.8 billion |
---|---|
Operating margin TTM | 19.02% |
Gross profit TTM | $6.8 billion |
Return on assets TTM | 6.56% |
Return on equity TTM | 14.58% |
Profit margin | 17.85% |
Book value | 35.929 |
Market capitalisation | $145.2 billion |
TTM: trailing 12 months
CSL's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CSL.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
CSL's total ESG risk score
Total ESG risk: 27.73
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CSL's overall score of 27.73 (as at 12/31/2018) is pretty good – landing it in it in the 40th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like CSL is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
CSL's environmental score
Environmental score: 3.04/100
CSL's environmental score of 3.04 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CSL is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
CSL's social score
Social score: 18.57/100
CSL's social score of 18.57 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that CSL is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
CSL's governance score
Governance score: 11.12/100
CSL's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that CSL is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
CSL's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. CSL scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that CSL has, for the most part, managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
CSL Ltd was last rated for ESG on: 2019-01-01.
Total ESG score | 27.73 |
---|---|
Total ESG percentile | 39.7 |
Environmental score | 3.04 |
Environmental score percentile | 5 |
Social score | 18.57 |
Social score percentile | 5 |
Governance score | 11.12 |
Governance score percentile | 5 |
Level of controversy | 2 |
CSL share dividends
Dividend payout ratio: 45.18% of net profits
Recently CSL has paid out, on average, around 45.18% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.33% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CSL shareholders could enjoy a 1.33% return on their shares, in the form of dividend payments. In CSL's case, that would currently equate to about A$2.64 per share.
While CSL's payout ratio might seem fairly standard, it's worth remembering that CSL may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 8 September 2024 (the "ex-dividend date").
Have CSL's shares ever split?
CSL's shares were split on a 3:1 basis on 17 October 2007. So if you had owned 1 share the day before the split, the next day you would own 3 shares. This wouldn't directly have changed the overall worth of your CSL shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for CSL shares which in turn could have impacted CSL's share price.
CSL share price volatility
Over the last 12 months, CSL's shares have ranged in value from as little as $225.5626 up to $311.2777. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while CSL's is 0.325. This would suggest that CSL's shares are less volatile than average (for this exchange).
CSL overview
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
CSL in the news
An Intrinsic Calculation For CSL Limited (ASX:CSL) Suggests It's 21% Undervalued
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgA Nephropathy
Half year reported NPATA US$2 billion¹,² Up 13% at constant currency³
Past developments
12 January 2023: Citi analysts have put a “buy” rating on CSL shares and lifted their 12-month price target to $340, implying potential upside of 22% from current levels. The brokerage said CSL is set to benefit from improved trading conditions in the plasma industry as well as the recent acquisition of Vifor Pharma. It expects the company’s EPS to grow 20% in FY 2023, 23% in FY 2024 and 15.9% in FY 2025.
Frequently asked questions
More guides on Finder
-
Australia’s top investment funds vs ChatGPT and Bard
We put Australia's top funds to the test against ChatGPT and Google's Bard to see which stock portfolio's were the best performing.
-
What are the best CHESS-sponsored brokers?
CHESS sponsorship allows you to directly own ASX listed shares in your own name, but it comes with some drawbacks. Find out if it's right for you.
-
Best performing stocks on the ASX in 2024 (Updated weekly)
Looking for the best performing stocks in Australia? We update this list weekly.
-
Tiger Brokers Australia review
If you're thinking of trading stocks with Tiger Brokers, check out our review of this online broker's fees, safety and pros and cons first.
-
The best AI stocks in the US and Australia in 2024
Here's what investors should know before adding AI stocks to their portfolios.
-
How to invest in the S&P 500
Find out the different ways you can invest in the S&P 500 index from Australia.
-
Saxo Invested Australia review: Share trading platform
Saxo Invested allows you to trade over 60,000 instruments on 50 global stock exchanges and provides lower commissions for active traders.
-
The cheapest stock brokers in Australia (Sep 2024)
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
-
What are dividends?
A dividend is the distribution of some of a company's profits that are paid regularly to its shareholders.
-
14 best share trading platforms Australia – ranked
Follow these tips to find the best share trading platform for you.
Ask a question